Tokyo Tape
Sign in
← Oncolys BioPharma

Annual report

4588.TEDINET S100QI26
Period2022-01-01 → 2022-12-31
Filed2023-03-30
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 78
MetricValuePeriodScopeSource row
Revenue¥976m2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥642m2021-01-01 → 2021-12-31StandaloneNet sales
Revenue¥314m2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥1.3bn2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Revenue¥169m2018-01-01 → 2018-12-31dStandaloneNet sales (5-year summary)
Operating income−¥1.2bn2022-01-01 → 2022-12-31StandaloneOperating income
Operating income−¥1.5bn2021-01-01 → 2021-12-31StandaloneOperating income
Ordinary income−¥1.2bn2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income−¥1.5bn2021-01-01 → 2021-12-31StandaloneOrdinary income
Ordinary income−¥1.7bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥539m2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.2bn2018-01-01 → 2018-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.1bn2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Profit before tax−¥1.6bn2021-01-01 → 2021-12-31StandaloneIncome before income taxes
Net income−¥1.1bn2022-01-01 → 2022-12-31StandaloneProfit loss
Net income−¥1.6bn2021-01-01 → 2021-12-31StandaloneProfit loss
Net income−¥2.1bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income−¥912m2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Net income−¥1.2bn2018-01-01 → 2018-12-31dStandaloneNet income loss (5-year summary)
Total assets¥2.7bnat 2022-12-31StandaloneAssets
Total assets¥4.3bnat 2021-12-31StandaloneAssets
Total assets¥2.8bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥4.4bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total assets¥3.4bnat 2018-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥492mat 2022-12-31StandaloneLiabilities
Total liabilities¥698mat 2021-12-31StandaloneLiabilities
Net assets / equity¥2.2bnat 2022-12-31StandaloneNet assets
Net assets / equity¥3.6bnat 2021-12-31StandaloneNet assets
Net assets / equity¥2.0bnat 2020-12-31dStandaloneNet assets
Net assets / equity¥3.5bnat 2019-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥2.9bnat 2018-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥1.7bnat 2022-12-31StandaloneCash and deposits
Cash and deposits¥3.5bnat 2021-12-31StandaloneCash and deposits
Cash & equivalents¥1.5bnat 2022-12-31StandaloneCash and cash equivalents
Cash & equivalents¥3.2bnat 2021-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.8bnat 2020-12-31dStandaloneCash and cash equivalents
Cash & equivalents¥3.1bnat 2019-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥2.2bnat 2018-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.7bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.7bn2021-01-01 → 2021-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.5bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥238m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.2bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow¥20m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥942,0002021-01-01 → 2021-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥38m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥4m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥342m2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥114m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥3.1bn2021-01-01 → 2021-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥242m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.1bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.1bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-66.312022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-95.52021-01-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-145.582020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-65.552019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-104.552018-01-01 → 2018-12-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥124.2at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥206.86at 2021-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥136.43at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥240.71at 2019-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥216.61at 2018-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio81.2%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio83.6%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio71.4%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio78.7%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio84.3%at 2018-12-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued17,405,200at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued17,405,200at 2021-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued14,641,900at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued14,331,300at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued13,346,000at 2018-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees33at 2022-12-31StandaloneNumber of employees
Employees33at 2021-12-31StandaloneNumber of employees
Employees32at 2020-12-31dStandaloneNumber of employees
Employees27at 2019-12-31dStandaloneNumber of employees
Employees30at 2018-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 849
ItemContextValueUnit
Subscription rights to sharesCurrentYearInstant_NonConsolidatedMember7680000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember3593992000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember2159269000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember4291876000JPY
Liabilities and net assetsCurrentYearInstant_NonConsolidatedMember2650959000JPY
Net salesPrior1YearDuration_NonConsolidatedMember642494000JPY
Net salesCurrentYearDuration_NonConsolidatedMember976182000JPY
Cost of service cos exp oaPrior1YearDuration_NonConsolidatedMember443690000JPY
Cost of service cos exp oaCurrentYearDuration_NonConsolidatedMember637695000JPY
Beginning finished goods cosPrior1YearDuration_NonConsolidatedMember8434000JPY
Beginning finished goods cosCurrentYearDuration_NonConsolidatedMember8434000JPY
Total beginning finished goods and cost of products manufactured for the periodPrior1YearDuration_NonConsolidatedMember8434000JPY
Total beginning finished goods and cost of products manufactured for the periodCurrentYearDuration_NonConsolidatedMember8434000JPY
Ending finished goods cosPrior1YearDuration_NonConsolidatedMember8434000JPY
Ending finished goods cosCurrentYearDuration_NonConsolidatedMember8434000JPY
Gross profitPrior1YearDuration_NonConsolidatedMember198803000JPY
Gross profitCurrentYearDuration_NonConsolidatedMember338487000JPY
Selling general and administrative expensesPrior1YearDuration_NonConsolidatedMember1653357000JPY
Selling general and administrative expensesCurrentYearDuration_NonConsolidatedMember1542993000JPY
Operating incomePrior1YearDuration_NonConsolidatedMember-1454554000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember-1204506000JPY
Interest income noiPrior1YearDuration_NonConsolidatedMember494000JPY
Interest income noiCurrentYearDuration_NonConsolidatedMember587000JPY
Dividends income noiPrior1YearDuration_NonConsolidatedMember3000JPY
Dividends income noiCurrentYearDuration_NonConsolidatedMember3000JPY
Foreign exchange gains noiPrior1YearDuration_NonConsolidatedMember37369000JPY
Foreign exchange gains noiCurrentYearDuration_NonConsolidatedMember62639000JPY
Other noiPrior1YearDuration_NonConsolidatedMember776000JPY
Other noiCurrentYearDuration_NonConsolidatedMember37000JPY
Non operating incomePrior1YearDuration_NonConsolidatedMember38643000JPY
Non operating incomeCurrentYearDuration_NonConsolidatedMember63267000JPY
Interest expenses noePrior1YearDuration_NonConsolidatedMember4169000JPY
Interest expenses noeCurrentYearDuration_NonConsolidatedMember3945000JPY
Amortization of restricted stock remuneration noePrior1YearDuration_NonConsolidatedMember68525000JPY
Amortization of restricted stock remuneration noeCurrentYearDuration_NonConsolidatedMember17793000JPY
Share acquisition rights issuance costs noePrior1YearDuration_NonConsolidatedMember413000JPY
Share acquisition rights issuance costs noeCurrentYearDuration_NonConsolidatedMember－JPY
Stock issuance cost noePrior1YearDuration_NonConsolidatedMember11652000JPY
Stock issuance cost noeCurrentYearDuration_NonConsolidatedMember30000JPY
Other noePrior1YearDuration_NonConsolidatedMember218000JPY
Other noeCurrentYearDuration_NonConsolidatedMember0JPY
Non operating expensesPrior1YearDuration_NonConsolidatedMember84977000JPY
Non operating expensesCurrentYearDuration_NonConsolidatedMember21769000JPY
Ordinary incomePrior1YearDuration_NonConsolidatedMember-1500888000JPY
Ordinary incomeCurrentYearDuration_NonConsolidatedMember-1163008000JPY
Gain on transfer of receivables eiPrior1YearDuration_NonConsolidatedMember－JPY
Gain on transfer of receivables eiCurrentYearDuration_NonConsolidatedMember21406000JPY
Extraordinary incomePrior1YearDuration_NonConsolidatedMember－JPY
Extraordinary incomeCurrentYearDuration_NonConsolidatedMember21406000JPY
Impairment loss elPrior1YearDuration_NonConsolidatedMember19845000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2021-12-31pass
balance sheet identitynon_consolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-12-31pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · operating cash flownon_consolidated 2021-01-01/2021-12-31pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2021-01-01/2021-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · total assetsnon_consolidated 2021-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass